
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Amplo is a global venture capital firm founded by Sheel Tyle in 2017, based in the United States. The firm focuses on supporting entrepreneurs who are building companies with significant societal impact. Amplo has raised three core funds to date, with a total of approximately $100 million targeted for its first fund. The firm has a portfolio of around 50 companies, reflecting its commitment to early-stage investments.
In 2026, Amplo transitioned into Collective Global, a multi-strategy investment platform with over $1 billion in assets under management (AUM). This evolution allows Amplo to leverage a broader investment strategy while maintaining its focus on early-stage ventures. The firm operates globally, with a particular emphasis on the United States, and has established a reputation for backing founders who are ambitious and committed to making a difference.
Amplo primarily invests in early-stage companies across sectors such as fintech, healthtech, artificial intelligence, and enterprise software. The firm targets investments at various stages, including pre-seed, seed, seed-plus, and Series A rounds. Amplo seeks to support globally ambitious companies that have the potential to create significant societal impact. The firm emphasizes a global-first approach, sourcing deals internationally and leveraging a high-profile advisory network.
Investment checks typically range from $500,000 to $5 million, aligning with standard norms for seed and Series A investments. Amplo looks for founders who demonstrate ambition and a commitment to building impactful businesses. The firm’s investment thesis underscores the importance of supporting companies that matter, particularly in sectors that address pressing global challenges.
Amplo's portfolio includes notable companies that exemplify its focus on impactful ventures:
These companies reflect Amplo's commitment to investing in sectors that have the potential for significant societal impact, particularly in technology and healthcare.
Sheel Tyle: Founder & CEO; previously a partner at NEA, Tyle co-founded Collective Global and has extensive experience in venture capital.
Sam Garcia: Partner; Garcia brings a wealth of experience in early-stage investments and has been instrumental in sourcing deals for Amplo.
Julia Gillard AC: Board Partner; the 27th Prime Minister of Australia, Gillard provides strategic insights and governance expertise.
John Key: Board Partner; the 38th Prime Minister of New Zealand, Key offers valuable perspectives on international markets and policy.
Peter Sands: Board Partner; Sands has a strong background in finance and investment management.
Alec Ross: Board Partner; Ross is known for his expertise in technology and innovation.
Leymah Gbowee: Board Partner; a Nobel Peace Prize laureate, Gbowee brings a unique perspective on social impact.
Whitney Wolfe Herd: Brand Partner; the founder of Bumble, Wolfe Herd adds insights into consumer technology and branding.
Ian Carnevale: Design Partner; Carnevale focuses on design and user experience in technology.
Dennis Thankachan: Venture Partner; Thankachan has experience in venture capital and startup operations.
To pitch Amplo, founders should visit their website at www.amplovc.com. The firm prefers direct applications through their online platform. Founders should include a clear overview of their business, market opportunity, and how their venture aligns with Amplo's investment thesis. Response times may vary, but founders can expect timely communication regarding their application status.
In 2026, Amplo transitioned into Collective Global, a multi-strategy investment platform with over $1 billion in AUM. This rebranding reflects the firm's evolution while maintaining its focus on early-stage ventures. Amplo continues to operate as the venture arm of Collective Global, emphasizing its commitment to impactful investments.
Notable portfolio companies include Robinhood, which went public in 2021, and Parsley Health, which was acquired by LifeMD. The firm has also invested in emerging companies like TravelPerk, which has achieved unicorn status.
What are Amplo's investment criteria?
Amplo invests in early-stage companies primarily in the fintech, healthtech, AI, and enterprise software sectors. The firm focuses on pre-seed, seed, seed-plus, and Series A stages, targeting globally ambitious founders.
How can I apply or pitch to Amplo?
Founders can pitch to Amplo by visiting their website at www.amplovc.com. The firm encourages direct applications through their online platform.
What makes Amplo different from other venture capital firms?
Amplo emphasizes a global-first approach and supports companies that aim to create meaningful societal impact. The firm leverages a high-profile advisory network to assist portfolio companies.
What is Amplo's geographic scope?
Amplo invests globally, with a strong focus on the United States. The firm seeks to identify opportunities in various international markets.
What is the typical check size for investments?
Amplo typically invests between $500,000 and $5 million in early-stage companies, aligning with standard practices for seed and Series A funding.
What kind of post-investment involvement does Amplo have?
Amplo provides ongoing support to its portfolio companies through access to a global network of advisors and board members, helping founders navigate challenges in building their businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.